Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Pearl Gan, OUCRU Photographer in Residence, for her winning image selected for the Lancet Highlights 2020: Framing Health Stories. Despite the difficulties of this pandemic year, The Lancet received fascinating and varied entries for our Highlights 2020 photography competition. 15 striking photographs were selected. Each picture captures a unique moment, highlighting a health story.

Photograph by Pearl Gan; Photographer in Residence, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. 
Manu is shown attending a long-lasting insecticidal net (LLIN) event in her local village in remote Cambodia. Many of the local people in her village work in the forests and have had malaria sometime in their lives. The villagers know the importance of LLINs for the prevention of mosquito-borne disease. In Cambodia, the nationwide LLIN programme was initiated to ensure these nets are distributed to local communities, such as farms and plantations in malaria-endemic zones, as identified by local district and health-centre staff. In these communities, the provision of LLINs matters because they can help save lives. © Pearl Gan, Lancet Highlights 2020: framing health stories

Pearl’s photograph – Combating malaria with long-lasting insecticidal nets portrays a woman, Manu, attending a long-lasting insecticidal net (LLIN) event in her local village in remote Cambodia. Many of the local people in her village work in the forests and have had malaria sometime in their lives.

The villagers know the importance of LLINs for the prevention of mosquito-borne disease. In Cambodia, the nationwide LLIN programme was initiated to ensure these nets are distributed to local communities, such as farms and plantations in malaria-endemic zones, as identified by local district and health-centre staff. In these communities, the provision of LLINs matters because they can help save lives.

Read the full story on the OUCRU website

Read the article Highlights 2020: framing health stories on The Lancet website

Similar stories

Prof Guy Thwaites co-authored WHO’s report on antibacterial agents in preclinical & clinical development

OUCRU’s Director, Professor Guy Thwaites, has recently contributed to an analysis of antibacterial agents in preclinical and clinical development by the World Health Organisation (WHO), as part of the WHO advisory group on research and development of antibacterial treatments.

Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications

OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.

OUCRU SPEAR Digital Diaries

Healthcare workers and community members in Indonesia, Nepal and Vietnam have been documenting their personal experiences of Covid-19. They have each made their own ‘digital diary’, using a range of creative tools and with technical support from the project team. These diaries form part of the SPEAR project: exploring the experiences and impacts of COVID-19 for healthcare workers and vulnerable communities.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Congratulations to our new Associate Professors

Our heartfelt congratulations to Melissa Kapulu, Francis Ndungu and Emelda Okiro from KWTRP, and to Hoa Thi Ngo and Sophie Yacoub from OUCRU who have been awarded Associate Professorships

First-of-its-kind study found equine antitoxin is safe and effective for the treatment of tetanus in adults

A first-of-its kind randomised controlled trial compared two different antitoxin treatments for tetanus. A comparison of human and equine intramuscular antitoxin in adults found that intramuscular equine antitoxin is safe and effective for treating tetanus in adults. Addition of additional intrathecal (spinal) antitoxin does not add any benefit compared to treatment with intramuscular antitoxin alone.